Curtis Given, MD
Neuroradiology · Lexington, KYNPI 1699717751
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (41.5%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 20 manufacturers reported payments, led by Stryker at 47.2% of the total. Reporting peaked in 2019 at $114,977 and has fallen 98.6% since, to $1,600 in 2025.
Across 362 payments — averaging $701.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$120K
- Medtronic$70K
- Genentech USA, Inc.$55K
- Siemens Medical Solutions USA, Inc.$7K
- Scientia Vascular$318
- Route 92 Medical, Inc.$166
- plus $728 from 14 others
Across 19 payments — averaging $6004.97 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Stryker$103K
- Medtronic$11K
What the payments were for
- Consulting fees$103,45541%
- Speaking & faculty fees$105,41042%
- Travel & lodging$33,68013%
- Food & beverage$11,3574%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 174 | $119,813 |
| Medtronic(2 entities) | 130 | $70,097 |
| Genentech USA, Inc. | 31 | $55,472 |
| Siemens Medical Solutions USA, Inc. | 3 | $7,309 |
| Scientia Vascular | 1 | $318 |
| Route 92 Medical, Inc. | 1 | $166 |
| Contego Medical, Inc | 3 | $155 |
| AstraZeneca | 1 | $108 |
| Microvention, Inc. | 1 | $97 |
| Abbott | 5 | $92 |
| Portola Pharmaceuticals, LLC | 2 | $52 |
| Johnson & Johnson | 1 | $43 |
| Balt USA, LLC | 1 | $37 |
| Asahi Intecc USA, Inc. | 1 | $24 |
| Integra Lifesciences Corporation | 1 | $23 |
| Boston Scientific | 1 | $22 |
| Cardiva Medical, Inc. | 1 | $21 |
| CSL Behring | 1 | $19 |
| Cardiovascular Systems Inc. | 2 | $19 |
| Angiodynamics, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SURPASS$61,889
- Pipeline$52,110
- SURPASS EVOLVE$45,605
- Activase$36,657
- Covidien-Access$5,675
- NEUROFORM ATLAS$4,427
- SOLITAIRE X$2,468
- TREVO$2,230
- Solitaire$2,078
- TARGET$1,731
- Onyx$1,505
- AXS CATALYST 7$716
- 1488, IDEAL EYES$656
- Aristotle$318
- Colossus$318
- Plato 17$318
- Socrates 38$318
- 8F Base Camp Sheath System$166
- 088 Access System$166
- CATALYST$158
How this compares
Too few neuroradiology providers in Kentuckyto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BrilintaTicagrelor | 32 | $14,894 |
| ClopidogrelClopidogrel Bisulfate | 87 | $419 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaBrilinta | $108 | $14,89432 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. There are too few neuroradiology providers in Kentuckyon file to place this against a meaningful peer group, so we don't.
Other neuroradiology in Lexington
- Shivani PahwaLexington$10K
- Kwaku ObengLexington$66
- Daniel ChondeLexington$39
- Melissa SmithLexington$38
- Tadesse EshetuLexington$11
- Robert BertLouisville$3K
- Richard DownsLouisville$185
- Ramin HamidiLouisville$128
- John ButmanLouisville$0
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.